Compare Stocks: TWST vs. ADPT vs. CDNA vs. BDSX

Market Snapshot

Current market context for the selected companies.

TWST

$150.04

Market Cap $9.50B

Sector Healthcare

Industry Diagnostics & Research

Data through 2026-08-26

ADPT

$26.17

Market Cap $4.19B

Sector Healthcare

Industry Diagnostics & Research

Data through 2026-08-26

CDNA

$51.01

Market Cap $2.63B

Sector Healthcare

Industry Diagnostics & Research

Data through 2026-08-26

BDSX

$30.63

Market Cap $296.22M

Sector Healthcare

Industry Diagnostics & Research

Data through 2026-08-26

Performance

Absolute returns and relative performance versus SPY.

Metric	TWST	ADPT	CDNA	BDSX
1 Month	+69.4%	+16.2%	+42.7%	+45.6%
1 Month vs SPY	+66.1%	+12.9%	+39.4%	+42.3%
3 Months	+133.8%	+89.1%	+130.2%	+106.8%
3 Months vs SPY	+131.8%	+87.1%	+128.2%	+104.8%
6 Months	+202.6%	+61.4%	+176.3%	+136.9%
6 Months vs SPY	+192.2%	+51.0%	+165.9%	+126.5%
1 Year	+447.8%	+106.6%	+300.1%	+212.6%
1 Year vs SPY	+428.6%	+87.4%	+280.9%	+193.4%
2 Years	+240.0%	+467.7%	+52.9%	-14.0%
2 Years vs SPY	+203.4%	+431.1%	+16.4%	-50.5%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	TWST	ADPT	CDNA	BDSX
Revenue Growth	23.2%	21.5%	52.2%	34.2%
Earnings Growth	—	—	—	—
Gross Margin	52.0%	46.9%	70.6%	82.5%
Operating Margin	-30.6%	-22.0%	0.2%	-20.0%
Net Margin	-31.7%	-20.7%	24.2%	-27.0%
Return on Equity	-29.6%	-38.8%	29.5%	-540.0%
Return on Assets	-13.1%	-4.1%	-0.3%	-14.1%

Valuation

Common valuation multiples shown side by side.

Metric	TWST	ADPT	CDNA	BDSX
P / E	—	—	22.8	—
Forward P / E	-239.1	-142.1	37.5	-127.6
P / S	20.4	13.2	5.4	2.6
P / B	19.8	28.5	5.7	29.3
EV / Sales	20.3	13.7	4.6	3.0
EV / EBIT	-66.3	-62.2	2,354.2	-15.0
P / FCF	-136.2	214.9	21.9	-24.6
FCF Yield	-0.7%	0.5%	4.6%	-4.1%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	TWST	ADPT	CDNA	BDSX
Free Cash Flow	-$64.82M	$18.98M	$112.16M	-$10.89M
Operating Cash Flow	-$53.07M	-$21.01M	$93.66M	-$19.83M
Debt / Equity	24.4%	272.5%	4.5%	785.2%

Earnings Outlook

Upcoming earnings expectations when available.

Metric	TWST	ADPT	CDNA	BDSX
Next Earnings	—	—	—	2026-11-03
EPS Estimate	—	—	—	-0.75
Revenue Estimate	—	—	—	27.56M
EPS Growth	—	—	—	+35.3%
Revenue Growth	—	—	—	+26.6%
Analyst Coverage	—	—	—	7